LY-627-2K

N/A

Report date: 2025/06/11 11:06:03

Base Information

Drug NameLY-627-2K
Drug Alias NameParathyroid Receptor Modulator (Eli Lilly/Therapeutics for Rare and Neglected Diseases)PTH Hormone Analog (Eli Lilly/TRND)Parathyroid Hormone Analog (Eli Lilly/Therapeutics for Rare and Neglected Diseases)PTH-RMLY-627-2K +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionParathyroid hormone replacementsCalcium metabolism modulatorsParathyroid hormone receptor agonists
TargetsParathyroid hormone receptor
Therapy Area/IndicationsHypoparathyroidismOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyTherapeutics For Rare And Neglected Diseases (Trnd)
Inactive CompaniesN/A
Active IndicationsHypoparathyroidism
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A